Showing results (731-740 of 803) with videos related to

Sort By:
Pageof 81
American Heart Journal|October 11, 2011
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AFJonathan P Piccini, Elizabeth S Fraulo, Jack E Ansell, et al.
Heart (British Cardiac Society)|June 28, 2020
Patterns of oral anticoagulation use with cardioversion in clinical practiceKyle Geurink, DaJuanicia Holmes, Michael D Ezekowitz, et al.
American Heart Journal|December 21, 2010
CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependentArshed A Quyyumi, Edmund K Waller, Jonathan Murrow, et al.
American Heart Journal|December 9, 2019
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillationSean D Pokorney, DaJuanicia N Holmes, Peter Shrader, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)Larry R Jackson, Peter Schrader, Laine Thomas, et al.
Plos One|August 25, 2020
Complications from percutaneous-left ventricular assist devices versus intra-aortic balloon pump in acute myocardial infarction-cardiogenic shockSaraschandra Vallabhajosyula, Anna V Subramaniam, Dennis H Murphree, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trialArie Pieter Kappetein, Patrick W Serruys, Joseph F Sabik, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryMichael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American Heart Association|August 25, 2017
The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities StudyPaul L Hess, Hussein R Al-Khalidi, Daniel J Friedman, et al.
American Heart Journal|March 25, 2014
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryEmily C O'Brien, DaJuanicia N Holmes, Jack E Ansell, et al.
Pageof 81